On July 18th, a Memorandum of Understanding (MOU) was signed between BGI Genomics, Faculty Of Medicine Siriraj Hospital at Mahidol University, Bangkok Genomics Innovation Public Company (the BGI Genomics Thailand Joint Venture Company), and Hemogen Hong Kong Alpha Technology, Ltd. This agreement focuses on enhancing Thalassemia prevention and treatment initiatives and facilitating collaborative efforts in cellular and gene therapy development. Prof. Apichat Asavamongkolkul, Dean of the Faculty of Medicine Siriraj Hospital, Mahidol University (second from right), Mr. Preecha Laohapongchana, Director of BANGKOK GENOMICS INNOVATION PUBLIC COMPANY (second from left), Dr. Chao Liu, CEO of HEMOGEN HONGKONG ALPHA TECHNOLOGY., LTD (first...